X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Piramal Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs PIRAMAL ENTERPRISES - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS PIRAMAL ENTERPRISES J.B.CHEMICALS/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 14.8 36.1 41.0% View Chart
P/BV x 2.3 3.0 78.0% View Chart
Dividend Yield % 0.2 0.8 20.4%  

Financials

 J.B.CHEMICALS   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
PIRAMAL ENTERPRISES
Mar-17
J.B.CHEMICALS/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs3182,095 15.2%   
Low Rs2001,025 19.5%   
Sales per share (Unadj.) Rs148.0492.8 30.0%  
Earnings per share (Unadj.) Rs19.172.6 26.3%  
Cash flow per share (Unadj.) Rs23.994.7 25.3%  
Dividends per share (Unadj.) Rs0.5021.00 2.4%  
Dividend yield (eoy) %0.21.3 14.4%  
Book value per share (Unadj.) Rs128.9862.5 15.0%  
Shares outstanding (eoy) m84.82172.56 49.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.73.2 55.2%   
Avg P/E ratio x13.621.5 63.1%  
P/CF ratio (eoy) x10.816.5 65.6%  
Price / Book Value ratio x2.01.8 111.0%  
Dividend payout %2.628.9 9.1%   
Avg Mkt Cap Rs m21,951269,194 8.2%   
No. of employees `0002.74.0 68.1%   
Total wages/salary Rs m1,84117,939 10.3%   
Avg. sales/employee Rs Th4,590.921,190.3 21.7%   
Avg. wages/employee Rs Th673.44,470.1 15.1%   
Avg. net profit/employee Rs Th592.13,120.0 19.0%   
INCOME DATA
Net Sales Rs m12,55185,037 14.8%  
Other income Rs m5422,338 23.2%   
Total revenues Rs m13,09387,374 15.0%   
Gross profit Rs m2,05534,991 5.9%  
Depreciation Rs m4123,817 10.8%   
Interest Rs m9620,310 0.5%   
Profit before tax Rs m2,08813,202 15.8%   
Minority Interest Rs m01,699 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-100 0.0%   
Tax Rs m4692,281 20.6%   
Profit after tax Rs m1,61912,520 12.9%  
Gross profit margin %16.441.1 39.8%  
Effective tax rate %22.517.3 130.0%   
Net profit margin %12.914.7 87.6%  
BALANCE SHEET DATA
Current assets Rs m7,77887,590 8.9%   
Current liabilities Rs m4,358185,578 2.3%   
Net working cap to sales %27.2-115.2 -23.6%  
Current ratio x1.80.5 378.1%  
Inventory Days Days5531 176.1%  
Debtors Days Days8048 168.3%  
Net fixed assets Rs m5,713108,523 5.3%   
Share capital Rs m170345 49.1%   
"Free" reserves Rs m10,547148,481 7.1%   
Net worth Rs m10,937148,826 7.3%   
Long term debt Rs m0144,957 0.0%   
Total assets Rs m15,574482,394 3.2%  
Interest coverage x22.81.7 1,383.0%   
Debt to equity ratio x01.0 0.0%  
Sales to assets ratio x0.80.2 457.2%   
Return on assets %11.06.8 161.7%  
Return on equity %14.88.4 175.9%  
Return on capital %20.012.0 167.0%  
Exports to sales %48.70-   
Imports to sales %7.10-   
Exports (fob) Rs m6,115NA-   
Imports (cif) Rs m889NA-   
Fx inflow Rs m6,16915,001 41.1%   
Fx outflow Rs m1,2855,150 25.0%   
Net fx Rs m4,8849,851 49.6%   
CASH FLOW
From Operations Rs m1,397-100,393 -1.4%  
From Investments Rs m-320-24,202 1.3%  
From Financial Activity Rs m-1,196135,705 -0.9%  
Net Cashflow Rs m-10211,110 -0.9%  

Share Holding

Indian Promoters % 55.4 52.9 104.7%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 4.0 84.8%  
FIIs % 3.9 26.6 14.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 16.5 224.2%  
Shareholders   30,437 93,274 32.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   NATCO PHARMA  PANACEA BIOTECH  CADILA HEALTHCARE  ABBOTT INDIA  PLETHICO PHARMA  

Compare J.B.CHEMICALS With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Day Flat; Oil and Gas Stocks Lead Losses(Closing)

After opening the day in red, share markets in India witnessed negative trading activity throughout the day and ended the day on a weak note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Feb 22, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS